Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 23,864	$ 26,585
Short-term investments	97,652	135,734
Prepaid expenses and other current assets	6,178	3,628
Total current assets	127,694	165,947
Property and equipment, net	236	270
In-process R&D	10,634	10,960
Other non-current assets	1,106	387
Total assets	139,670	177,564
Current liabilities:
Accounts payable	3,386	3,504
Accrued expenses and other current liabilities	7,900	7,093
Total current liabilities	11,286	10,597
Long-term liabilities:
Long-term debt	26,484	26,348
Other long-term liabilities	169	247
Total liabilities	37,939	37,192
Commitments and Contingencies (Note 9)
Stockholders’ equity:
Common stock, $0.001 par value, 300,000,000 authorized as of June 30, 2024 and December 31, 2023; 138,199,047 and 138,143,545 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	140	140
Additional paid-in capital	538,429	533,872
Accumulated other comprehensive loss	(880)	(271)
Accumulated deficit	(435,958)	(393,369)
Total stockholders’ equity	101,731	140,372
Total liabilities and stockholders’ equity	$ 139,670	$ 177,564